114 related articles for article (PubMed ID: 415443)
1. Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole.
Flockhart IR; Large P; Troup D; Malcolm SL; Marten TR
Xenobiotica; 1978 Feb; 8(2):97-105. PubMed ID: 415443
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
[TBL] [Abstract][Full Text] [Related]
3. Some aspects of the metabolism of misonidazole.
Flockhart IR; Malcolm SL; Marten TR; Parkins CS; Ruane RJ; Troup D
Br J Cancer Suppl; 1978 Jun; 3():264-7. PubMed ID: 277244
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
Workman P
Cancer Clin Trials; 1980; 3(3):237-51. PubMed ID: 7438321
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization by tinidazole: pharmacokinetic study.
Cossu F; Rombi GP; Mazza S; Facchini A
Int J Clin Pharmacol Res; 1986; 6(4):317-23. PubMed ID: 3759284
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
Gianni L; Jenkins JF; Greene RF; Lichter AS; Myers CE; Collins JM
Cancer Res; 1983 Feb; 43(2):913-6. PubMed ID: 6848201
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
Agrawal KC; Rupp WD; Rockwell S
Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
[TBL] [Abstract][Full Text] [Related]
8. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
Zacchei AG; Weidner LL; Besselaar GH; Raftery EB
Drug Metab Dispos; 1976; 4(4):387-401. PubMed ID: 8295
[TBL] [Abstract][Full Text] [Related]
9. Metabolic potentiation of the radiosensitization of hypoxic bacterial cells afforded by nitroaromatic compounds.
Anderson RF; Patel KB
Radiat Res; 1983 Mar; 93(3):516-24. PubMed ID: 6344127
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole.
White R; Workman P; Owen L
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):473-6. PubMed ID: 7107369
[TBL] [Abstract][Full Text] [Related]
12. Targeting radiosensitizers to DNA by attachment of an intercalating group: nitroimidazole-linked phenanthridines.
Cowan DS; Panicucci R; McClelland RA; Rauth AM
Radiat Res; 1991 Jul; 127(1):81-9. PubMed ID: 2068275
[TBL] [Abstract][Full Text] [Related]
13. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitization of human colorectal tumor cells by 4-nitro-5-sulfonatoimidazoles.
Fitzpatrick DA; Heindel ND; Egolf RA; Walton H
Radiat Res; 1989 Jan; 117(1):47-58. PubMed ID: 2913608
[TBL] [Abstract][Full Text] [Related]
15. Effect of hepatic microsomal enzyme inducers on the metabolism of misonidazole in rats.
Shoemaker D; Upton D; Strong J
Cancer Treat Rep; 1980; 64(2-3):275-7. PubMed ID: 7407761
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
Brown JM; Yu NY; Workman P
Br J Cancer; 1979 Mar; 39(3):310-20. PubMed ID: 465300
[TBL] [Abstract][Full Text] [Related]
17. Glutathione depletion by 2-nitroimidazole-1-acetohydroxamic acid as a radiosensitizer in hypoxic rat hepatocytes.
Takanuki K; Igarashi T; Hata K; Hori H; Shibata T; Kitagawa H; Satoh T; Inayama S
Biochem Int; 1988 Jul; 17(1):155-62. PubMed ID: 3190713
[TBL] [Abstract][Full Text] [Related]
18. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
[TBL] [Abstract][Full Text] [Related]
19. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A
Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Nitrofurantoin (CAS No. 67-20-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Sep; 341():1-218. PubMed ID: 12724784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
